The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome.
about
Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a reviewLongitudinal anti-müllerian hormone in women with polycystic ovary syndrome: an acupuncture randomized clinical trial.Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients.The role of anti-Müllerian hormone in female fertility and infertility - an overview.Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.Ontogeny of the ovary in polycystic ovary syndrome.Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism.Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction.Anti-Müllerian hormone as a marker of ovarian reserve: an update.Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).Anti-Müllerian hormone in women with polycystic ovary syndrome.Impact of hypocaloric dietary intervention on ovulation in obese women with PCOS.The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial.Anti-Mullerian hormone (AMH): what do we still need to know?Ghrelin is independently associated with anti-mullerian hormone levels in obese but not non-obese women with polycystic ovary syndrome.
P2860
Q26774060-29A35265-F1DC-46E2-9130-89A3EBE966D0Q28388248-3C116616-8C1F-44B2-BE1A-031E86DFC622Q34226461-577A15C9-6589-45B3-AD19-94D4CA07E7FFQ34278051-90AA0C6E-580C-4475-BEE3-0649492F6A34Q34817037-59A3E352-F3C9-4942-8B42-7EBCEC267FCBQ36035618-1147D42F-8D68-44D9-B151-3FA9A621CA5AQ36360786-6627F843-61F3-4A61-B2B8-327F429364FCQ36381560-BF75C574-D2ED-4A36-8B6B-F090C01845D2Q37173546-F64635AF-6E03-4035-83D4-6E24C1CAFB24Q37346173-5EF2D855-4025-480B-8C49-5E1E1F0D143DQ37606149-14A0FF63-8469-4006-BA2C-B7F0BE93D9D6Q37885328-F24AF508-0F00-41D2-BA50-D4379DF53C82Q38801473-0226DD95-122E-41BB-9B95-97427E7234A2Q41640666-6993BA60-5B69-4B55-B775-3075E108370BQ42880659-686834B3-D4F4-4484-9D42-FC1557263AFAQ45972242-B7083F2B-C8BB-4571-807B-9492F35DADDAQ48126292-7B784446-5F62-476D-B68B-647104B86C21
P2860
The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
The use of anti-mullerian horm ...... ith polycystic ovary syndrome.
@en
The use of anti-mullerian horm ...... ith polycystic ovary syndrome.
@nl
type
label
The use of anti-mullerian horm ...... ith polycystic ovary syndrome.
@en
The use of anti-mullerian horm ...... ith polycystic ovary syndrome.
@nl
prefLabel
The use of anti-mullerian horm ...... ith polycystic ovary syndrome.
@en
The use of anti-mullerian horm ...... ith polycystic ovary syndrome.
@nl
P921
P356
P1476
The use of anti-mullerian horm ...... ith polycystic ovary syndrome.
@en
P2093
Manny Noakes
Robert J Norman
P304
P356
10.1210/JC.2007-1188
P407
P577
2007-07-24T00:00:00Z